+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hydrophobic Interaction Chromatography Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • PDF Icon


  • 120 Pages
  • January 2022
  • Region: Global
  • Mordor Intelligence
  • ID: 4987015
UP TO OFF until Dec 31st 2023

The global hydrophobic interaction chromatography market is expected to witness a CAGR of 7.6% over the forecast period. The growth is attributed to increasing demand for monoclonal antibodies in the treatment of many fatal diseases coupled with growing R&D investments in the biopharmaceutical industry. Moreover, the increasing number of cancer cases and a wide range of applications of hydrophobic interaction chromatography in monoclonal antibodies is expected to boost the market growth over the forecast period. In addition, an increasing number of contract research organization and contract manufacturing organization around the world is projected to bolster the usage of hydrophobic interaction chromatography. However, lack of skilled professionals coupled with stringent regulations expected to hamper the market growth over the forecast period.

Key Market Trends

Monoclonal Antibodies Sample Segment are expected to Grow at Significant Rate

Monoclonal antibodies are identical antibodies that are produced artificially through genetic engineering from parent cells. The monoclonal antibodies are used extensively in cancer treatment, bone marrow transplantation and many other therapeutic applications. Hydrophobic interaction chromatography is widely used in purification of monoclonal antibodies. The factors such as increasing R&D in developing monoclonal antibodies for various applications in various diseases, especially in cancer coupled with advancements in technologies are fuelling the segment growth over the forecast period. In addition, recent product launches and approval of many monoclonal antibodies by government authorities are fuelling the usage of hydrophobic interaction chromatography. Moreover, increasing spending by the pharma and biopharmaceutical companies on the purification of proteins for better clinical outcomes is expected to boost the market growth.

The growing number of cancer cases further increasing the demand for the novel antibodies and fuelling the usage of hydrophobic interaction chromatography.

North America is Expected to have Significant Market Share

North America is projected to have significant market share owing to the factors such as increasing R&D investment and growing healthcare spending in the region. Furthermore, an increasing number of cancer cases coupled with the presence of key market players with focus on product innovations is expected to boost the market growth. According to the National Institutes of Health, an estimated 1,735,350 new cancer cases are diagnosed in 2018. Furthermore, cancer deaths are fell 26% in 2015 compared to 1991. Asia Pacific region is expected to have significant market growth owing to the presence of a large number of contract research organizations, companies’ interest in expanding into the emerging Asian countries to fill the market gap.

Competitive Landscape

Global hydrophobic interaction chromatography market is moderately fragmented and competitive. Market players are focusing on product innovations, new product launches and regional expansions to increase their market share. The key market players operating in hydrophobic interaction chromatography market include Bio-Rad Laboratories, Inc., Thermo Fisher Scientific, General Electric, Sartorius AG and Tosoh Bioscience GmbH among others.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Demand for Monoclonal Antibodies
4.2.2 Increasing R&D investment in Oncology and Analytic Techniques
4.3 Market Restraints
4.3.1 Lack of Skilled Professionals
4.3.2 Availability of Other Chromatography Techniques
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5.1 By Products
5.1.1 Columns
5.1.2 Resins
5.1.3 Buffers
5.2 By Sample Type
5.2.1 Monoclonal Antibodies
5.2.2 Vaccines
5.2.3 Others
5.3 End-User
5.3.1 Contract Research Organizations
5.3.2 Pharma and Biopharmaceutical Companies
5.3.3 Others
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.4.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 Bio-Rad Laboratories, Inc.
6.1.2 General Electric
6.1.3 Sartorius AG
6.1.4 Tosoh Bioscience GmbH
6.1.5 Waters Corporation
6.1.6 KNAUER
6.1.7 Sepax Technologies, Inc.
6.1.8 Merck KGaA.
6.1.9 JNC Corporation
6.1.10 Geno Technology Inc., USA.

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Bio-Rad Laboratories, Inc.
  • General Electric
  • Sartorius AG
  • Tosoh Bioscience GmbH
  • Waters Corporation
  • Sepax Technologies, Inc.
  • Merck KGaA.
  • JNC Corporation
  • Geno Technology Inc., USA.